| |
| | Cell Culture Drug Resistance Testing - Misconceptions |
 | | The assay results are categorized as "sensitive", "intermediate," or "resistant," based on comparisons with other assays in the database, with "sensitive" neoplasms falling at one end of the spectrum, and "resistant" neoplasms at the other. |
 | | The prototypic DISC assay, in which living and dead cells are differentially stained (allowing identification of tumor cells in mixed populations of tumor cells and normal cells) and where the endpoint is delayed loss of membrane integrity. |
 | | The findings in Figure 6 show conclusively that the cell death assays are broadly applicable to a wide range of human neoplasms, ranging from low response rate tumors, such as pancreatic cancer and cholangiocarcinoma (group 1, the non-colon, non-stomach GI adenocarcinomas) to acute lymphoblastic leukemia (group 11), and including breast cancer. |
| www.weisenthal.org /chapt04.htm (2151 words) |
|